Skip to main content
Fig. 2 | BMC Neurology

Fig. 2

From: Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)

Fig. 2

Location and severity of spasticity. The location of spasticity in terms of upper and lower limb involvement is shown. The severity of spasticity, as assessed by neurologists, was classified into severe, moderate and mild spasticity. It was recorded on a 4-point scale and classified as follows: severe spasticity: 4 points, moderate spasticity: 3 points, mild spasticity: 2 points, no spasticity: 1 point

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us